Profile picture

Professor Matthias Pfisterer

Muenchenstein (Switzerland)
Membership: FESC Member
Follow
Logo ESC

Contributor content

Drug-eluting stents with biodegradable polymers: are enough data in for a final assessment?
Journal
Drug-eluting stents with biodegradable polymers: are enough data in for a final assessment?
16 February 2014
Long-term benefit–risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET
Journal
Long-term benefit–risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET
25 November 2008
Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study
Journal
Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study
19 July 2007
Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET): reply
Journal
Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET): reply
2 July 2007
Targeted stent use in clinical practice based on evidence from the BAsel Stent Cost Effectiveness Trial (BASKET)<sup> </sup>
Journal
Targeted stent use in clinical practice based on evidence from the BAsel Stent Cost Effectiveness Trial (BASKET)<sup> </sup>
13 February 2007